In the univariate Cox regression analysis for progression-free survival (PFS), an increase in carcinoembryonic antigen (CEA) levels was significantly associated with a higher risk of disease progression (HR: 1.003, 95% CI: 1.001–1.004, p = 0.003), highlighting the adverse prognostic impact of tumor burden. Here, CEACAM5 is linked to neoplasm.